FDA NDC Directory · JSON-LD · Markdown

Dihydroergotamine Mesylate

NDC 81284-411 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerProvepharm Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA212046
Dosage form / routeINJECTION, SOLUTION · INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Active ingredientsDIHYDROERGOTAMINE MESYLATE (1 mg/mL)
Marketing started20210930
Package count2

External sources

Source: openFDA. Public-domain (CC0).